UWS
UTHR icon

Unique Wealth Strategies’s United Therapeutics UTHR Stock Holding History

Unique Wealth Strategies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,105
Closed -$655K – 272
2026
Q1 		$655K Sell
1,105
-141
-11% -$70.2K 0.27% 96
2025
Q4 		$607K Buy
+1,246
New +$580K 0.24% 126

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Unique Wealth Strategies's UTHR Position: Q2 2026 in Review

Unique Wealth Strategies sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 1,105 shares — an estimated $655K sold.

Unique Wealth Strategies first reported a position in UTHR in Q4 2025 and held it in 2 quarters. The position peaked at $655K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Unique Wealth Strategies reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Unique Wealth Strategies sold 1,105 United Therapeutics shares in Q2 2026, an estimated $655K.
  • Unique Wealth Strategies first reported a position in United Therapeutics in Q4 2025 and held it in 2 quarters.
  • Unique Wealth Strategies's United Therapeutics position peaked at $655K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Unique Wealth Strategies's 13F filing for Q2 2026, filed 15 Jul 2026.